Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Moertel

Showing results (121-130 of 251) with videos related to

Pageof 26
Sort By:
Cancer Research|June 1, 1972
Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancerC G Moertel, A J Schutt, R J Reitemeier, et al.
Cancer Chemotherapy Reports|April 1, 1972
Phase II study of 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in advanced gastrointestinal cancerC G Moertel, A J Schutt, R J Reitemeier, et al.
The New England Journal of Medicine|November 7, 1985
Rapid reversal of carcinoid crisis with a somatostatin analogueL K Kvols, J K Martin, H M Marsh, et al.
Cancer Research|October 1, 1973
A phase 2 study of intermittent high-dose cyclophosphamide therapy of advanced gastrointestinal cancerA J Schutt, R G Hahn, R J Reitemeier, et al.
The New England Journal of Medicine|December 31, 1987
Carcinoid tumor of the appendix: treatment and prognosisC G Moertel, L H Weiland, D M Nagorney, et al.
Cancer|August 1, 1976
Sequential and combination chemotherapy of advanced gastric cancerC G Moertel, J A Mittelman, R F Bakemeier, et al.
American Journal of Clinical Oncology|April 1, 1983
A phase II study of alanosine in advanced large bowel carcinomaJ Rubin, V Hineman, C G Moertel, et al.
Journal of the National Cancer Institute|January 1, 1978
Early clinical study of an intermittent schedule for maytansine (NSC-153858): brief communicationR T Eagan, J N Ingle, J Rubin, et al.
Cancer|November 1, 1978
Chemotherapy studies in primary liver cancer: a prospective randomized clinical trialG Falkson, C G Moertel, P Lavin, et al.
Cancer|December 15, 1988
A phase I clinical trial of recombinant human tumor necrosis factorE T Creagan, J S Kovach, C G Moertel, et al.
Pageof 26

Showing results (121-130 of 251) with videos related to

Sort By:
Pageof 26
Cancer Research|June 1, 1972
Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancerC G Moertel, A J Schutt, R J Reitemeier, et al.
Cancer Chemotherapy Reports|April 1, 1972
Phase II study of 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in advanced gastrointestinal cancerC G Moertel, A J Schutt, R J Reitemeier, et al.
The New England Journal of Medicine|November 7, 1985
Rapid reversal of carcinoid crisis with a somatostatin analogueL K Kvols, J K Martin, H M Marsh, et al.
Cancer Research|October 1, 1973
A phase 2 study of intermittent high-dose cyclophosphamide therapy of advanced gastrointestinal cancerA J Schutt, R G Hahn, R J Reitemeier, et al.
The New England Journal of Medicine|December 31, 1987
Carcinoid tumor of the appendix: treatment and prognosisC G Moertel, L H Weiland, D M Nagorney, et al.
Cancer|August 1, 1976
Sequential and combination chemotherapy of advanced gastric cancerC G Moertel, J A Mittelman, R F Bakemeier, et al.
American Journal of Clinical Oncology|April 1, 1983
A phase II study of alanosine in advanced large bowel carcinomaJ Rubin, V Hineman, C G Moertel, et al.
Journal of the National Cancer Institute|January 1, 1978
Early clinical study of an intermittent schedule for maytansine (NSC-153858): brief communicationR T Eagan, J N Ingle, J Rubin, et al.
Cancer|November 1, 1978
Chemotherapy studies in primary liver cancer: a prospective randomized clinical trialG Falkson, C G Moertel, P Lavin, et al.
Cancer|December 15, 1988
A phase I clinical trial of recombinant human tumor necrosis factorE T Creagan, J S Kovach, C G Moertel, et al.
Pageof 26